Carglumic Acid: An Emerging “Weapon” In The Treatment Of Acute Hyperammonemia
Carglumic acid, sold under brands such as Carbaglu, is used as an adjuvant therapy for…
News
Elosulfase Alpha: Paving The Way For The Rebirth Of Mucopolysaccharidosis Type IV
Elosulfase alpha is sold under the brand Vimizim and is a medication used to treat…
Thymopentin For Injection: New Hope For Immunodeficiency Patients
With Thymopentin for Injection (Th immunodeficiency, immune system disorders, and immunotherapy for certain chronic diseases.…
Cefpirome Sulfate for Injection: A New Hope in Fighting Resistant Infections
Cefpirome Sulfate for Injection is making headlines as an emerging option for the treatment of…
Sorafenib Tosylate Tablets: A New Star in Cancer Treatment
In recent years, Sorafenib Tosylate tablets have garnered significant attention as an important targeted therapy…
New Hydroxyurea Tablet Approved for Treatment of Multiple Blood Disorders
[January 16, 2025] – Recently, the National Drug Administration (NMPA) formally approved an improved hydroxyurea…
Carmofur Tablets: The Latest Advancement in Anti-cancer Drugs
In recent years, research in the field of cancer treatment has continued to make breakthroughs,…
Eliglustat: Embark On A New Journey In The Treatment Of Type 1 Gaucher Disease
Eliglustat tartrate capsules are used to treat type 1 Gaucher’s disease. As a new type…
Vigabatrin: Assist Patients With Infantile Spasms In Returning To Normal Life
Vigabatrin powder for oral solution is a medication used to treat infantile spasms and refractory…
Asfotase Alfa: Frontier Drugs For The Treatment Of Juvenile Hypophosphatemia
Asfotase alfa is sold under the brand Strensiq and is a medication used to treat…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights